Search

everythinglearnresearchcommunity

for

Search:↓

Follistatin, known for inhibiting myostatin and promoting muscle growth in mice, is being discussed as a potential treatment for hair loss. Specific treatments mentioned include Minoxidil, Finasteride, and RU58841.

The conversation discusses a user's impressive hair regrowth progress over 17 months using a topical minoxidil and finasteride spray from HIMS, with suggestions to add microneedling for better results. Some users express skepticism about the authenticity of the results, while others inquire about side effects and application methods.

Dutasteride is often more effective than finasteride for blocking DHT, but results vary and some may experience side effects. Combining minoxidil with either medication can improve hair regrowth, but switching doesn't guarantee better results for everyone.

Dutasteride users report mixed experiences, with some experiencing significant hair shedding and others seeing improvement after initial shedding. Many users switch from finasteride to dutasteride, hoping for better results, but reactions vary widely, with some facing allergies or worsening hair loss.

Dutasteride mesotherapy combined with topical minoxidil led to some hair regrowth, but taking dutasteride pills every 2-3 days showed more noticeable results. The user did not try finasteride, as their dermatologist recommended dutasteride for better outcomes with fewer side effects at a reduced dosage.

The user has high DHT levels despite using dutasteride, which may not be effective due to potential damage or spoilage. They are considering a hair transplant if DHT levels don't decrease after two years.

The user experiencing diffuse hair loss is using various treatments including RU58841, finasteride, minoxidil with tretinoin, anti-hair loss shampoo, and microneedling, and is considering adding peptides TB500, BPC157, and GHK-Cu. They have low growth hormone levels and are questioning its impact on hair loss, while another user suggests androgenic alopecia and androgens are likely the main cause of hair loss.

Hair loss theory involves 3alpha-hydroxysteroid reductase (3AHD) converting DHT to androstenol. Discussion explores potential treatments and encourages more research.

27F with androgenic alopecia since 17 seeks treatment. Tried spironolactone, caused low blood pressure; believes finasteride is safer and wants to try it.

The user shared their 6-month progress using 0.25 mg finasteride, topical minoxidil, and dermastamping, noting good results but experiencing increased sleepiness. Another user suggested minoxidil might be causing the sleepiness, and the original poster considered adjusting their treatment.